Upadacitinib – July 2021

• Brand names:
  • Rinvoq®
• Pharmaceutical Company:
  • AbbVie Pty Ltd
• Condition/Indication: Severe atopic dermatitis
• Meeting Date: July 2021
• Public Summary Document (PSD) July 2021 PBAC Meeting - (PDF 1798KB)
• Public Summary Document (PSD) July 2021 PBAC Meeting - (Word 289KB)

Related Public Summary Documents

• Upadacitinib – November 2021